For CRC patients, early detection and diagnosis are of great significance for a good outcome, and carcinoembryonic antigen (CEA), the most used biomarker for noninvasively detection, is less effective due to poor sensitivity (93). Here, CEACAM5 is linked to colorectal carcinoma.